COVID-19, Anticoagulation, and the 2020 Virtual ISTH Meeting

 

Drs. Jeffrey Weitz and Saskia Middledorp discuss how COVID-19 has impacted thromboembolism and ultimately anticoagulation management. They discuss the COVID-19 coagulopathy, its risk, and how to best prevent thrombosis.

Previous Article Advancing Care for Hemophilia – Insights from the 2020 Meeting
Next Article Key Findings/Learnings from the 2020 Meeting Related to Anticoagulation
Print

Theme picker